Vascular regeneration therapy using autologous peripheral blood mononuclear cells for refractory skin ulcer associated with connective tissue diseases and vasculitis - PBMC transplantation for ulcer associated with connective tissue diseases and vasculitis

Kumamoto University0 个研究点目标入组 10 人开始时间: 2016年11月23日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•1) Patients whose have severe hypersensitivity or history of side effects to aphaeresis 2) Patients whose have malignant tumor or history of malignancy within the past 5 year 3) Patients whose have suffering acute myocardial infarction, unstable angina pectoris, myocarditis or cerebral infarction within 3 months 4) Patients whose circulatory dynamics are remarkably unstable due to severe heart failure, arrhythmia and the like (in the case where it is judged that it is desirable for cardiovascular medical specialists to avoid this treatment) 5) Patients with active infection 6) Patients whose are pregnant or might be pregnant 7) Patients with proliferative diabetic retinopathy (untreated, medium-term and late proliferative retinopathy) the end of treatment example is excluded 8) Patients with less than serum albumin 2 mg/dL 9) Patients whose are judged inappropriate for this trial by their attending physician

发起方